221 related articles for article (PubMed ID: 26429875)
1. URGCP promotes non-small cell lung cancer invasiveness by activating the NF-κB-MMP-9 pathway.
Cai J; Li R; Xu X; Zhang L; Wu S; Yang T; Fang L; Wu J; Zhu X; Li M; Huang Y
Oncotarget; 2015 Nov; 6(34):36489-504. PubMed ID: 26429875
[TBL] [Abstract][Full Text] [Related]
2. G9a Promotes Invasion and Metastasis of Non-Small Cell Lung Cancer through Enhancing Focal Adhesion Kinase Activation via NF-κB Signaling Pathway.
Sun T; Zhang K; Pangeni RP; Wu J; Li W; Du Y; Guo Y; Chaurasiya S; Arvanitis L; Raz DJ
Mol Cancer Res; 2021 Mar; 19(3):429-440. PubMed ID: 33298547
[TBL] [Abstract][Full Text] [Related]
3. Src Promotes Metastasis of Human Non-Small Cell Lung Cancer Cells through Fn14-Mediated NF-κB Signaling.
Wang W; Liu F; Wang C; Wang C; Tang Y; Jiang Z
Med Sci Monit; 2018 Mar; 24():1282-1294. PubMed ID: 29500337
[TBL] [Abstract][Full Text] [Related]
4. URGCP/URG4 promotes apoptotic resistance in bladder cancer cells by activating NF-κB signaling.
Wu M; Chen J; Wang Y; Hu J; Liu C; Feng C; Zeng X
Oncotarget; 2015 Oct; 6(31):30887-901. PubMed ID: 26429874
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-26b suppresses the metastasis of non-small cell lung cancer by targeting MIEN1 via NF-κB/MMP-9/VEGF pathways.
Li D; Wei Y; Wang D; Gao H; Liu K
Biochem Biophys Res Commun; 2016 Apr; 472(3):465-70. PubMed ID: 26827826
[TBL] [Abstract][Full Text] [Related]
6. CTHRC1 induces non-small cell lung cancer (NSCLC) invasion through upregulating MMP-7/MMP-9.
He W; Zhang H; Wang Y; Zhou Y; Luo Y; Cui Y; Jiang N; Jiang W; Wang H; Xu D; Li S; Wang Z; Chen Y; Sun Y; Zhang Y; Tseng HR; Zou X; Wang L; Ke Z
BMC Cancer; 2018 Apr; 18(1):400. PubMed ID: 29631554
[TBL] [Abstract][Full Text] [Related]
7. TRIM47 overexpression is a poor prognostic factor and contributes to carcinogenesis in non-small cell lung carcinoma.
Han Y; Tian H; Chen P; Lin Q
Oncotarget; 2017 Apr; 8(14):22730-22740. PubMed ID: 28186994
[TBL] [Abstract][Full Text] [Related]
8. Id-1 promotes migration and invasion of non-small cell lung cancer cells through activating NF-κB signaling pathway.
Li J; Li Y; Wang B; Ma Y; Chen P
J Biomed Sci; 2017 Dec; 24(1):95. PubMed ID: 29233161
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA SLCO4A1-AS1 drives the progression of non-small-cell lung cancer by modulating miR-223-3p/IKKα/NF-κB signaling.
Li Q; Jiang B; Qi Y; Zhang H; Ma H
Cancer Biol Ther; 2020 Sep; 21(9):806-814. PubMed ID: 32687454
[TBL] [Abstract][Full Text] [Related]
10. Apoptosis induction and AKT/NF-κB inactivation are associated with regroafenib-inhibited tumor progression in non-small cell lung cancer in vitro and in vivo.
Weng MC; Li MH; Chung JG; Liu YC; Wu JY; Hsu FT; Wang HE
Biomed Pharmacother; 2019 Aug; 116():109032. PubMed ID: 31163381
[TBL] [Abstract][Full Text] [Related]
11. SRPX2 promotes cell proliferation and invasion via activating FAK/SRC/ERK pathway in non-small cell lung cancer.
Li X; Liu J; Sun H; Zou Y; Chen J; Chen Y; Chen C; Wu X
Acta Biochim Pol; 2020 Jun; 67(2):165-172. PubMed ID: 32550700
[TBL] [Abstract][Full Text] [Related]
12. TPX2 Promotes Metastasis and Serves as a Marker of Poor Prognosis in Non-Small Cell Lung Cancer.
Zhou F; Wang M; Aibaidula M; Zhang Z; Aihemaiti A; Aili R; Chen H; Dong S; Wei W; Maimaitiaili A
Med Sci Monit; 2020 Aug; 26():e925147. PubMed ID: 32748897
[TBL] [Abstract][Full Text] [Related]
13. High-mobility group box 1-mediated matrix metalloproteinase-9 expression in non-small cell lung cancer contributes to tumor cell invasiveness.
Liu PL; Tsai JR; Hwang JJ; Chou SH; Cheng YJ; Lin FY; Chen YL; Hung CY; Chen WC; Chen YH; Chong IW
Am J Respir Cell Mol Biol; 2010 Nov; 43(5):530-8. PubMed ID: 19933377
[TBL] [Abstract][Full Text] [Related]
14. CD151 drives cancer progression depending on integrin α3β1 through EGFR signaling in non-small cell lung cancer.
Zhu J; Cai T; Zhou J; Du W; Zeng Y; Liu T; Fu Y; Li Y; Qian Q; Yang XH; Li Q; Huang JA; Liu Z
J Exp Clin Cancer Res; 2021 Jun; 40(1):192. PubMed ID: 34108040
[TBL] [Abstract][Full Text] [Related]
15. IL-17A/IL-17RA promotes invasion and activates MMP-2 and MMP-9 expression via p38 MAPK signaling pathway in non-small cell lung cancer.
Wu Z; He D; Zhao S; Wang H
Mol Cell Biochem; 2019 May; 455(1-2):195-206. PubMed ID: 30564960
[TBL] [Abstract][Full Text] [Related]
16. Tripartite motif-containing 37 (TRIM37) promotes the aggressiveness of non-small-cell lung cancer cells by activating the NF-κB pathway.
Li Y; Deng L; Zhao X; Li B; Ren D; Yu L; Pan H; Gong Q; Song L; Zhou X; Dai T
J Pathol; 2018 Nov; 246(3):366-378. PubMed ID: 30043491
[TBL] [Abstract][Full Text] [Related]
17. Visfatin Triggers the Cell Motility of Non-Small Cell Lung Cancer via Up-Regulation of Matrix Metalloproteinases.
Wang G; Tian W; Liu Y; Ju Y; Shen Y; Zhao S; Zhang B; Li Y
Basic Clin Pharmacol Toxicol; 2016 Dec; 119(6):548-554. PubMed ID: 27224551
[TBL] [Abstract][Full Text] [Related]
18. RIP1 Is a Novel Component of γ-ionizing Radiation-Induced Invasion of Non-Small Cell Lung Cancer Cells.
Kang AR; Cho JH; Lee NG; Song JY; Hwang SG; Lee DH; Um HD; Park JK
Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32605153
[No Abstract] [Full Text] [Related]
19. URG4/URGCP enhances the angiogenic capacity of human hepatocellular carcinoma cells in vitro via activation of the NF-κB signaling pathway.
Xing S; Zhang B; Hua R; Tai WC; Zeng Z; Xie B; Huang C; Xue J; Xiong S; Yang J; Liu S; Li H
BMC Cancer; 2015 May; 15():368. PubMed ID: 25947641
[TBL] [Abstract][Full Text] [Related]
20. The role of cytochrome c oxidase subunit Va in non-small cell lung carcinoma cells: association with migration, invasion and prediction of distant metastasis.
Chen WL; Kuo KT; Chou TY; Chen CL; Wang CH; Wei YH; Wang LS
BMC Cancer; 2012 Jun; 12():273. PubMed ID: 22748147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]